COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives

Data de publicação: Data Ahead of Print:

Unidades de investigação

Abstract

[No abstract available]

Dados da publicação

ISSN/ISSNe:
1873-9946, 1876-4479

JOURNAL OF CROHNS & COLITIS  Oxford University Press

Tipo:
Editorial Material
Páginas:
1343-1344
Link para outro recurso:
www.scopus.com

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • COVID-19; COVID-19 Vaccines; Humans; Inflammatory Bowel Diseases; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Vaccination; ad26.cov2 s; ibacovavec; immunoglobulin G; infliximab; mercaptopurine; mesalazine; methotrexate; SARS-CoV-2 vaccine; tozinameran; ustekinumab; vaxzevria; vedolizumab; tumor necrosis factor inhibitor; antibody response; cellular immunity; coronavirus disease 2019; disease activity; Editorial; human; humoral immunity; immune response; immunoglobulin blood level; inflammatory bowel disease; monotherapy; adverse event; epidemiology; inflammatory bowel disease; prevention and control; vaccination

Proyectos asociados

Gut microbiome and IBD therapy: an interplay?

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (GutIBD) . 2021

Iron deficiency and inflammatory bowel disease. Correlation with inflammation and Vitamin D status.

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (IronIBD) . 2021

Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients.

Investigador Principal: Fernando José Magro Dias

Estudo Observacional Académico (4WARD) . 2021

Isolated Ulceration of Crohn’s Anastomosis

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2021

Therapeutic Drug Monitoring: An Emergent Approach in Inflammatory Bowel Disease

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2021

Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal

Investigador Principal: Fernando José Magro Dias

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação